Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Lymphoma

Free Subscription Articles published in Blood Retrieve available abstracts of 241 articles: HTML format

Single Articles

June 2009
1. SUZUKI R , Suzumiya J, Oshimi K
   Differences between nasal and extranasal NK/T-cell lymphoma.
   Blood. 2009;113:6260-1.
   PubMed     Related articles   
   
   
   
2. REN M , Li X, Cowell JK
   Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-FGFR1 chimeric tyrosine kinase.
   Blood. 2009.
   PubMed     Related articles    Abstract available
   
   
   
3. GASCOYNE RD
   Stem cells in Hodgkin lymphoma?
   Blood. 2009;113:5694.
   PubMed     Related articles   
   
   
   
4. CLAVIEZ A , Canals C, Dierickx D, Stein J, et al
   Allogeneic hematopoietic stem cell transplantation in children and adolescents with recurrent and refractory Hodgkin's lymphoma: an analysis of the European Group for Blood and Marrow Transplantation.
   Blood. 2009.
   PubMed     Related articles    Abstract available
   
   
   May 2009
5. KOHLHOF H , Hampel F, Hoffmann R, Burtscher H, et al
   Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
   Blood. 2009;113:5506-15.
   PubMed     Related articles    Abstract available
   
   
   
6. CI W , Polo JM, Cerchietti L, Shaknovich R, et al
   The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL.
   Blood. 2009;113:5536-48.
   PubMed     Related articles    Abstract available
   
   
   
7. CUI YX , Kerby A, McDuff FK, Ye H, et al
   NPM-ALK inhibits the p53 tumor suppressor pathway in an MDM2 and JNK-dependent manner.
   Blood. 2009;113:5217-27.
   PubMed     Related articles    Abstract available
   
   
   
8. RE A , Michieli M, Casari S, Allione B, et al
   High dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long term results of the GICAT study with analysis of prognostic factors.
   Blood. 2009.
   PubMed     Related articles    Abstract available
   
   
   
9. GOLDENBERG DM
   Some like it hot: lymphoma radioimmunotherapy.
   Blood. 2009;113:4823-4.
   PubMed     Related articles   
   
   
   
10. LONG HM , Zuo J, Leese AM, Gudgeon NH, et al
    CD4+ T cell clones recognising human lymphoma-associated antigens: generation by in vitro stimulation with autologous Epstein-Barr virus-transformed B cells.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
11. VAN LEEUWEN MT , Grulich AE, Webster AC, McCredie MR, et al
    Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
12. NOVAK U , Rinaldi A, Kwee I, Nandula SV, et al
    The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Blood. 2009;113:4918-21.
    PubMed     Related articles    Abstract available
    
    
    
13. PAGEL JM , Orgun N, Hamlin DK, Wilbur DS, et al
    A comparative analysis of conventional and pretargeted radioimmunotherapy of B-cell lymphomas by targeting CD20, CD22, and HLA-DR singly and in combinations.
    Blood. 2009;113:4903-13.
    PubMed     Related articles    Abstract available
    
    
    
14. DEANGELIS LM
    Primary central nervous system lymphoma: coming or going?
    Blood. 2009;113:4483-4.
    PubMed     Related articles   
    
    
    
15. SHI P , Lai R, Lin Q, Iqbal AS, et al
    IGF-IR tyrosine kinase interacts with NPM-ALK oncogene to induce survival of T-cell ALK+ anaplastic large-cell lymphoma cells.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
16. RITZ O , Guiter C, Castellano F, Dorsch K, et al
    Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
17. FU L , Lin-Lee YC, Pham LV, Tamayo AT, et al
    BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
    Blood. 2009;113:4627-36.
    PubMed     Related articles    Abstract available
    
    
    
18. KENNAH E , Ringrose A, Zhou LL, Esmailzadeh S, et al
    Identification of tyrosine kinase, HCK, and tumor suppressor, BIN1, as potential mediators of AHI-1 oncogene in primary and transformed CTCL cells.
    Blood. 2009;113:4646-55.
    PubMed     Related articles    Abstract available
    
    
    
19. ZHANG J , Jima DD, Jacobs C, Fischer R, et al
    Patterns of microRNA expression characterize stages of human B-cell differentiation.
    Blood. 2009;113:4586-94.
    PubMed     Related articles    Abstract available
    
    
    
20. LAN Q , Morton LM, Armstrong B, Hartge P, et al
    Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of three population-based case-control studies.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    April 2009
21. HOGLUND A , Nilsson LM, Forshell LP, Maclean KH, et al
    Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.
    Blood. 2009;113:4281-8.
    PubMed     Related articles    Abstract available
    
    
    
22. GERBER HP , Kung-Sutherland M, Stone I, Morris-Tilden C, et al
    Potent antitumor activity of the anti-CD19 auristatin antibody drug conjugate hBU12-vcMMAE against rituximab-sensitive and -resistant lymphomas.
    Blood. 2009;113:4352-61.
    PubMed     Related articles    Abstract available
    
    
    
23. MARNEROS AG , Grossman ME, Silvers DN, Husain S, et al
    Pralatrexate-induced tumor cell apoptosis in the epidermis of a patient with HTLV-1 adult T-cell lymphoma/leukemia (ATLL) causing skin erosions.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
24. DUNLEAVY K , Pittaluga S, Czuczman MS, Dave S, et al
    Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B cell lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
25. ROSSI EA , Goldenberg DM, Cardillo TM, Stein R, et al
    Hexavalent bispecific antibodies represent a new class of anticancer therapeutics: 1. properties of anti-CD20/CD22 antibodies in lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
26. STEFANOVIC A , Lossos IS
    Extranodal marginal zone lymphoma of the ocular adnexa.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
27. MALUMBRES R , Sarosiek KA, Cubedo E, Ruiz JW, et al
    Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas.
    Blood. 2009;113:3754-64.
    PubMed     Related articles    Abstract available
    
    
    
28. DAYDE D , Ternant D, Ohresser M, Lerondel S, et al
    Tumor burden influences exposure and response to rituximab: pharmacokinetic-pharmacodynamic modeling using a syngeneic bioluminescent murine model expressing human CD20.
    Blood. 2009;113:3765-72.
    PubMed     Related articles    Abstract available
    
    
    
29. DENT AL
    Going retro on lymphoma.
    Blood. 2009;113:3393-4.
    PubMed     Related articles   
    
    
    
30. KREJSGAARD T , Vetter-Kauczok CS, Woetmann A, Kneitz H, et al
    Ectopic expression of B lymphoid kinase in cutaneous T-cell lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
31. AI WZ , Tibshirani R, Taidi B, Czerwinski D, et al
    Anti-idiotype antibody response after vaccination correlates with better overall survival in follicular lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
32. RIBRAG V , Koscielny S, Casasnovas O, Cazeneuve C, et al
    Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
    Blood. 2009;113:3307-13.
    PubMed     Related articles    Abstract available
    
    
    March 2009
33. CLIFFORD GM , Rickenbach M, Lise M, Dal Maso L, et al
    Hodgkin lymphoma in the Swiss HIV Cohort Study.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
34. GOPAL AK , Pagel JM, Fromm JR, Wilbur S, et al
    I-131-anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
35. CHRISTOPEIT M , Schutte V, Theurich S, Weber T, et al
    Rituximab reduces the incidence of acute graft-versus-host disease.
    Blood. 2009;113:3130-1.
    PubMed     Related articles   
    
    
    
36. WANG T , Jiang Q, Chan C, Gorski KS, et al
    Inhibition of activation-induced death of dendritic cells and enhancement of vaccine efficacy via blockade of MINOR.
    Blood. 2009;113:2906-13.
    PubMed     Related articles    Abstract available
    
    
    
37. GIBLIN W , Chatterji M, Westfield G, Masud T, et al
    Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
    Blood. 2009;113:2965-75.
    PubMed     Related articles    Abstract available
    
    
    
38. GUPTA M , Dillon SR, Ziesmer SC, Feldman AL, et al
    APRIL mediates follicular lymphoma B cell proliferation and cyclin D1 expression through PI3-kinase regulated mTOR activation.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
39. DIEZ-MARTIN JL , Balsalobre P, Re A, Michieli M, et al
    Comparable survival between HIV positive and HIV negative non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
40. BOCCALATTE FE , Voena C, Riganti C, Bosia A, et al
    The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCL.
    Blood. 2009;113:2776-90.
    PubMed     Related articles    Abstract available
    
    
    
41. HAGNER PR , Mazan-Mamczarz K, Dai B, Corl S, et al
    Alcohol consumption and decreased risk of non-Hodgkin's lymphoma: role of mTOR dysfunction.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
42. FRANK MJ , Dawson DW, Bensinger SJ, Hong JS, et al
    Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.
    Blood. 2009;113:2478-87.
    PubMed     Related articles    Abstract available
    
    
    
43. MARTIN-SUBERO JI , Kreuz M, Bibikova M, Bentink S, et al
    New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.
    Blood. 2009;113:2488-97.
    PubMed     Related articles    Abstract available
    
    
    
44. BRADFORD PT , Devesa SS, Anderson WF, Toro JR, et al
    Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3,884 cases.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
45. HORKHEIMER I , Quigley M, Zhu J, Huang X, et al
    Induction of type I IFN is required for overcoming tumor-specific T cell tolerance following stem cell transplantation.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
46. AKHTARI M , Waller EK
    Howell-Jolly bodies in patients with chronic GVHD.
    Blood. 2009;113:2125.
    PubMed     Related articles   
    
    
    February 2009
47. O'HARA AJ , Wang L, Dezube BJ, Harrington WJ Jr, et al
    Tumor suppressor micro RNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
48. HIRAGA J , Tomita A, Sugimoto T, Shimada K, et al
    Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
49. WHITECROSS KF , Alsop AE, Cluse LA, Wiegmans A, et al
    Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors.
    Blood. 2009;113:1982-91.
    PubMed     Related articles    Abstract available
    
    
    
50. DE BRUIN ML , Burgers JA, Baas P, van 't Veer MB, et al
    Malignant mesothelioma following radiation treatment for Hodgkin's lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
51. KURTOVA AV , Tamayo AT, Ford RJ, Burger JA, et al
    Mantle cell lymphoma cells express high levels of CXCR4, CXCR5, and VLA-4 (CD49d): importance for interactions with the stromal microenvironment and specific targeting.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
52. JOSHI I , Minter LM, Telfer J, Demarest RM, et al
    Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
    Blood. 2009;113:1689-98.
    PubMed     Related articles    Abstract available
    
    
    
53. BASHEY A , Medina B, Corringham S, Pasek M, et al
    CTLA4 blockade with ipilimumab to treat relapse of malignancy after allogeneic hematopoietic cell transplantation.
    Blood. 2009;113:1581-8.
    PubMed     Related articles    Abstract available
    
    
    
54. CARLOTTI E , Wrench D, Matthews J, Iqbal S, et al
    Transformation of follicular lymphoma to diffuse large B cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
55. CALABRO ML , Gasperini P, Di Gangi IM, Indraccolo S, et al
    Anti-neoplastic activity of lentiviral vectors expressing interferon-alpha in a preclinical model of primary effusion lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
56. HILCHEY SP , Hyrien O, Mosmann TR, Livingstone AM, et al
    Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a "vaccinal effect" of rituximab.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
57. JONES RJ , Gocke CD, Kasamon YL, Miller CB, et al
    Circulating clonotypic B cells in classical Hodgkin's lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    January 2009
58. SHARKEY RM , Press OW, Goldenberg DM
    A re-examination of radioimmunotherapy in the treatment of non-Hodgkin lymphoma: Prospects for dual-targeted antibody/radioantibody therapy.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
59. GOLDENBERG DM , Rossi EA, Stein R, Cardillo TM, et al
    Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody.
    Blood. 2009;113:1062-70.
    PubMed     Related articles    Abstract available
    
    
    
60. TAM CS , Bassett R, Ledesma C, Korbling M, et al
    Mature results of the MD Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
61. CHO SH , Goenka S, Henttinen T, Gudapati P, et al
    PARP-14, a member of the B aggressive lymphoma (BAL) family, transduces survival signals in primary B cells.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
62. BOEHME V , Schmitz N, Zeynalova S, Loeffler M, et al
    CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: An analysis of patients treated in the RICOVER-60 trial of the German high-grade non-Hodgkin lymphoma study group (DSHNHL).
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
63. O'SHEA D , O'Riain C, Gupta M, Waters R, et al
    Regions of acquired uniparental disomy at diagnosis of follicular lymphoma are associated with both overall survival and risk of transformation.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
64. CORNEJO MG , Kharas MG, Werneck MB, Le Bras S, et al
    Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplant models.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
65. SAUER S , Erba PA, Petrini M, Menrad A, et al
    Expression of the oncofetal ED-B containing fibronectin isoform in hematologic tumors enables ED-B targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.
    Blood. 2009.
    PubMed     Related articles    Abstract available
    
    
    
66. TUN HW , McKinney M
    Differential gene expression of central nervous system lymphoma.
    Blood. 2009;113:267-8.
    PubMed     Related articles   
    
    
    
67. RUBENSTEIN JL , Shen A, Batchelor TT, Kadoch C, et al
    Differential gene expression in central nervous system lymphoma.
    Blood. 2009;113:266-7.
    PubMed     Related articles   
    
    
    
68. LEITNER WW , Baker MC, Berenberg TL, Lu MC, et al
    Enhancement of DNA tumor vaccine efficacy by gene gun-mediated codelivery of threshold amounts of plasmid-encoded helper antigen.
    Blood. 2009;113:37-45.
    PubMed     Related articles    Abstract available
    
    
    
69. VAN DOORN R , van Kester MS, Dijkman R, Vermeer MH, et al
    Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.
    Blood. 2009;113:127-36.
    PubMed     Related articles    Abstract available
    
    
    December 2008
70. CHETAILLE B , Bertucci F, Finetti P, Esterni B, et al
    Molecular profiling of classical Hodgkin's lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
71. MCCANN KJ , Ashton-Key M, Smith K, Stevenson FK, et al
    Primary CNS lymphoma: tumor-related clones exist in the blood and bone marrow with evidence for separate development.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
72. ANSELL SM
    Wnt-erizing mantle cell lymphoma.
    Blood. 2008;112:4783-4.
    PubMed     Related articles   
    
    
    
73. ASANO N , Yamamoto K, Tamaru JI, Oyama T, et al
    Age-related EBV-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classical Hodgkin lymphoma in elderly patients.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
74. TRUMAN LA , Ford CA, Pasikowska M, Pound JD, et al
    CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis.
    Blood. 2008;112:5026-36.
    PubMed     Related articles    Abstract available
    
    
    
75. ILLIDGE TM , Bayne M, Brown NS, Chilton S, et al
    Phase I/II study of fractionated 131I-rituximab in low grade B-cell lymphoma: The effect of prior rituximab dosing and tumor burden on subsequent radioimmunotherapy.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
76. CHEN J , Fiskus W, Eaton K, Fernandez P, et al
    Co-treatment with BCL-2 antagonist sensitizes cutaneous T cell lymphoma to lethal action of HDAC7-Nur77 based mechanism.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
77. COLT JS , Rothman N, Severson RK, Hartge P, et al
    Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
78. LEVY DS , Kahana JA, Kumar R
    AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
79. JAFFE ES , Harris NL, Stein H, Isaacson PG, et al
    Classification of lymphoid neoplasms: the microscope as a tool for disease discovery.
    Blood. 2008;112:4384-99.
    PubMed     Related articles    Abstract available
    
    
    November 2008
80. JOHNSON NA , Boyle M, Bashashati A, Leach S, et al
    Diffuse large B cell lymphoma: reduced CD20 expression is associated with an inferior survival.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
81. AU WY , Weisenburger DD, Intragumtornchai T, Nakamura S, et al
    Clinical differences between nasal and extranasal NK/T-cell lymphoma: a study of 136 cases from the International Peripheral T-cell Lymphoma Project.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
82. AMENGUAL JE , Zhang X, Ibrahim S, Gardner LB, et al
    Regression of HIV-related diffuse large B-cell lymphoma in response to antiviral therapy alone.
    Blood. 2008;112:4359-60.
    PubMed     Related articles   
    
    
    
83. NAUSCH N , Galani IE, Schlecker E, Cerwenka A, et al
    Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells.
    Blood. 2008;112:4080-9.
    PubMed     Related articles    Abstract available
    
    
    
84. LU X , Malumbres R, Shields B, Jiang X, et al
    PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling.
    Blood. 2008;112:4098-108.
    PubMed     Related articles    Abstract available
    
    
    
85. SANDER S , Bullinger L, Klapproth K, Fiedler K, et al
    MYC stimulates EZH2 expression by repression of its negative regulator miR-26a.
    Blood. 2008;112:4202-12.
    PubMed     Related articles    Abstract available
    
    
    
86. SCHLIEMANN C , Palumbo A, Zuberbuhler K, Villa A, et al
    Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
87. BEA S , Salaverria I, Armengol L, Pinyol M, et al
    Uniparental disomies, homozygous deletions, amplifications and target genes in mantle cell lymphoma revealed by integrative high-resolution whole genome profiling.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
88. YOUNG RM , Hardy IR, Clarke RL, Lundy N, et al
    Mouse models of non-Hodgkins lymphoma reveal Syk as an important therapeutic target.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
89. ACQUAVIVA J , Chen X, Ren R
    IRF-4 functions as a tumor suppressor in early B-cell development.
    Blood. 2008;112:3798-806.
    PubMed     Related articles    Abstract available
    
    
    
90. LIU FT , Agrawal SG, Movasaghi Z, Wyatt PB, et al
    Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib.
    Blood. 2008;112:3835-46.
    PubMed     Related articles    Abstract available
    
    
    October 2008
91. KATZENBERGER T , Kalla J, Leich E, Stocklein H, et al
    A distinctive subtype of t(14;18) negative nodal follicular non-Hodgkin lymphoma characterized by a predominantly diffuse growth pattern and deletions in the chromosomal region 1p36.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
92. CHNG WJ , Remstein ED, Fonseca R, Bergsagel PL, et al
    Gene expression profiling of pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma identifies new biological insights with potential diagnostic and therapeutic applications.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
93. GYAN E , Foussard C, Bertrand P, Michenet P, et al
    High dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: A randomized multicenter study by the GOELAMS. Final results with a median follow-up of nine years
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
94. MIYAZAKI K , Yamaguchi M, Imai H, Kobayashi T, et al
    Gene expression profiling of peripheral T-cell lymphoma including {gamma}{delta} T-cell lymphoma.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
95. CARBONE A , Cesarman E, Spina M, Gloghini A, et al
    HIV-associated lymphomas and gamma-herpesviruses.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
96. HOUOT R , Levy R
    T cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
97. INOMATA M , Tagawa H, Guo YM, Kameoka Y, et al
    MicroRNA-17-92 downregulates expression of distinct targets in different B-cell lymphoma subtypes.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
98. CERCHIETTI LC , Yang SN, Shaknovich R, Hatzi K, et al
    A peptomimetic inhibitor of BCL6 with potent anti-lymphoma effects in vitro and in vivo.
    Blood. 2008.
    PubMed     Related articles    Abstract available
    
    
    
99. VAN MALDEGEM F , van Dijk R, Wormhoudt TA, Kluin PM, et al
    The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment.
    Blood. 2008;112:3355-61.
    PubMed     Related articles    Abstract available
    
    
    
100. PAOLUZZI L , Gonen M, Bhagat G, Furman RR, et al
     The BH3-only mimetic ABT-737 synergizes the antineoplastic activity of proteasome inhibitors in lymphoid malignancies.
     Blood. 2008;112:2906-16.
     PubMed     Related articles    Abstract available
     
     
     September 2008
101. TJON JM , Verbeek WH, Kooy-Winkelaar YM, Nguyen BH, et al
     Defective synthesis or association of T cell receptor chains underlies loss of surface T cell receptor-CD3 expression in enteropathy associated T cell lymphoma.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
102. BRODY JD , Goldstein MJ, Czerwinski DK, Levy R, et al
     Immunotransplant preferentially expands Teffector cells over Tregulatory cells and cures large lymphoma tumors.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
103. DI NICOLA M , Zappasodi R, Carlostella C, Mortarini R, et al
     Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunological responses in indolent B cell lymphoma patients with relapsed and measurable disease: a pilot study.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
104. MONTESINOS-RONGEN M , Siebert R, Deckert M
     Primary lymphoma of the central nervous system - just DLBCL or not?
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
105. SALLES G , Mounier N, de Guibert S, Morschhauser F, et al
     Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
106. MORTON LM , Wang SS, Cozen W, Linet MS, et al
     Etiologic heterogeneity among non-Hodgkin lymphoma subtypes.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
107. BRENNAN RM , Burrows SR
     A mechanism for the HLA-A*01-associated risk for EBV+ Hodgkin lymphoma and infectious mononucleosis.
     Blood. 2008;112:2589-90.
     PubMed     Related articles   
     
     
     
108. KHOURI IF
     Response: Choice of conditioning for allogeneic transplantation in follicular lymphoma: nonmyeloablative or high-dose chemotherapy?
     Blood. 2008;112:2586-7.
     PubMed     Related articles   
     
     
     
109. VAN BESIEN K , Hari P
     Nonmyeloablative conditioning for relapsed follicular lymphoma.
     Blood. 2008;112:2585-6.
     PubMed     Related articles   
     
     
     
110. SPEER TW
     Fully human monoclonal antibodies and targeted radionuclide therapy.
     Blood. 2008;112:2584-5.
     PubMed     Related articles   
     
     
     
111. SHAH JJ , Fayad L, Romaguera J
     Mantle Cell International Prognostic Index (MIPI) not prognostic after R-hyper-CVAD.
     Blood. 2008;112:2583.
     PubMed     Related articles   
     
     
     
112. CHIRON D , Bekeredjian-Ding I, Pellat-Deceunynck C, Bataille R, et al
     Toll-like receptors: lessons to learn from normal and malignant human B cells.
     Blood. 2008;112:2205-13.
     PubMed     Related articles    Abstract available
     
     
     
113. NEWRZELA S , Cornils K, Li Z, Baum C, et al
     Resistance of mature T cells to oncogene transformation.
     Blood. 2008;112:2278-86.
     PubMed     Related articles    Abstract available
     
     
     
114. FUKUMOTO R , Andresen V, Bialuk I, Cecchinato V, et al
     In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
115. GELEBART P , Anand M, Armanious H, Peters AC, et al
     Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
116. CUTLER C , Stevenson K, Kim HT, Richardson P, et al
     Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
117. LEBIEN TW , Tedder TF
     B lymphocytes: how they develop and function.
     Blood. 2008;112:1570-80.
     PubMed     Related articles    Abstract available
     
     
     August 2008
118. ORZECHOWSKA BU , Powers MF, Sprague J, Li H, et al
     Rhesus macaque rhadinovirus-associated non-Hodgkin's lymphoma: animal model for KSHV associated malignancies.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
119. KOBE C , Dietlein M, Franklin J, Markova J, et al
     Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first line chemotherapy in advanced-stage Hodgkin lymphoma.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
120. LAN Q , Lim U, Liu CS, Weinstein SJ, et al
     A prospective study of mitochondrial DNA copy number and risk of non-Hodgkin lymphoma.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
121. CHEUNG KJ , Shah SP, Steidl C, Johnson N, et al
     Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
122. KRISTINSSON SY , Bjorkholm M, Goldin LR, McMaster ML, et al
     Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenstrom's macroglobulinemia patients: A population-based study in Sweden.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
123. STOLZ C , Hess G, Hahnel PS, Grabellus F, et al
     Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to Rituximab-induced apoptosis.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
124. LAMPRECHT B , Kreher S, Anagnostopoulos I, Johrens K, et al
     Aberrant expression of the Th2 cytokine IL-21 in Hodgkin lymphoma cells regulates STAT3 signaling and attracts Treg cells via regulation of MIP-3{alpha}
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
125. CALVO KR , Dabir B, Kovach A, Devor C, et al
     IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
126. LI YX , Fang H, Liu QF, Lu J, et al
     Clinical features and treatment outcome of nasal-type NK/T cell lymphoma of Waldeyer's ring.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
127. GOPAL AK , Press OW, Wilbur SM, Maloney DG, et al
     Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab.
     Blood. 2008;112:830-5.
     PubMed     Related articles    Abstract available
     
     
     July 2008
128. KINDLER T , Cornejo MG, Scholl C, Liu J, et al
     K-RasG12D-induced T-cell lymphoblastic lymphoma/leukemias harbor Notch1 mutations and are sensitive to {gamma}-secretase inhibitors.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
129. ARULOGUN SO , Prince HM, Ng J, Lade S, et al
     Long term outcomes of patients with advanced-stage cutaneous T cell lymphoma and large cell transformation.
     Blood. 2008.
     PubMed     Related articles    Abstract available
     
     
     
130. HABERMANN TM , Wang SS, Maurer MJ, Morton LM, et al
     Host immune gene polymorphisms in combination with clinical and demographic factors predicts late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
131. KUO SH , Yeh PY, Chen LT, Wu MS, et al
     Overexpression of B-cell activating factor of TNF family (BAFF) is associated with Helicobacter pylori-independent growth of gastric diffuse large B-cell lymphoma with histologic evidence of MALT lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
132. O'SHEA D , O'Riain C, Taylor C, Waters R, et al
     The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and a poorer overall survival.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
133. GEISLER CH , Kolstad A, Laurell A, Andersen NS, et al
     Long-term progression-free survival of mantle cell lymphoma following intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: A non-randomized phase-II multicenter study by the Nordic Lymphoma Group.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
134. MEAD GM , Barrans SL, Qian W, Walewski J, et al
     A prospective clinicopathological study of dose modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     June 2008
135. GERSTNER ER , Abrey LE, Schiff D, Ferreri AJ, et al
     CNS Hodgkin lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
136. SENFF NJ , Noordijk EM, Kim YH, Bagot M, et al
     European Organization for Research and Treatment of Cancer (EORTC) and International Society for Cutaneous Lymphoma (ISCL) consensus recommendations for the management of cutaneous B-cell lymphomas.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
137. YOUNG KH , Leroy K, Moller MB, Colleoni GW, et al
     Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
138. DE RE V , De Vita S, Sansonno D, Toffoli G, et al
     Mixed cryoglobulinemia syndrome as an additional autoimmune disorder associated with risk for lymphoma development.
     Blood. 2008;111:5760.
     PubMed     Related articles   
     
     
     
139. WLODARSKA I , Dierickx D, Vanhentenrijk V, Van Roosbroeck K, et al
     Translocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas.
     Blood. 2008;111:5683-90.
     PubMed     Related articles    Abstract available
     
     
     
140. RIMSZA LM , Leblanc ML, Unger JM, Miller TP, et al
     Gene expression predicts overall survival in paraffin embedded tissues of diffuse large B cell lymphoma treated with R-CHOP.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
141. BUGLIO D , Georgiakis GV, Hanabuchi S, Arima K, et al
     Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
142. 
     Atypical lymphocytes in Hodgkin disease.
     Blood. 2008;111:5416.
     PubMed     Related articles   
     
     
     May 2008
143. RUMINY P , Jardin F, Picquenot JM, Parmentier F, et al
     S{micro} mutation patterns suggest different progression pathways in follicular lymphoma: early direct or late from FL progenitor-cells.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
144. KLAPPER W , Szczepanowski M, Burkhardt B, Berger H, et al
     Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
145. TILL BG , Jensen MC, Wang J, Chen EY, et al
     Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
146. KLUIN-NELEMANS HC , Coenen JL, Boers JE, van Imhoff GW, et al
     EBV-positive immunodeficiency lymphoma after alemtuzumab-CHOP therapy for peripheral T-cell lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
147. MINARD-COLIN V , Xiu Y, Poe JC, Horikawa M, et al
     Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc{gamma}RI, Fc{gamma}RIII, and Fc{gamma}RIV.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
148. CHEN RW , Bemis LT, Amato CM, Myint H, et al
     Truncation in CCND1 mRNA alters miR-16-1 regulation in mantle cell lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
149. HIDAKA T , Nakahata S, Hatakeyama K, Hamasaki M, et al
     Down-regulation of TCF8 is involved in the leukemogenesis of adult-T cell leukemia/lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
150. DAVE SS
     Follicular lymphoma and the microenvironment.
     Blood. 2008;111:4427-8.
     PubMed     Related articles   
     
     
     
151. CONTASSOT E , Kerl K, Roques S, Shane R, et al
     Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression.
     Blood. 2008;111:4780-7.
     PubMed     Related articles    Abstract available
     
     
     
152. DI BARTOLO DL , Cannon M, Liu YF, Renne R, et al
     KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor.
     Blood. 2008;111:4731-40.
     PubMed     Related articles    Abstract available
     
     
     April 2008
153. MALUMBRES R , Chen J, Tibshirani R, Johnson NA, et al
     Paraffin-based 6-gene model predicts outcome in diffuse large B-cell lymphoma patients treated with R-CHOP.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
154. SCHOLLKOPF C , Melbye M, Munksgaard L, Smedby KE, et al
     Borrelia infection and risk of non-Hodgkin lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
155. AYDIN S , Rossi D, Bergui L, D'Arena G, et al
     CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter's syndrome?
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
156. RENUKARADHYA GJ , Khan MA, Vieira M, Du W, et al
     Type I NKT cells protect (and Type II NKT cells suppress) the host's innate antitumor immune response to a B cell lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
157. KHOURI IF , McLaughlin P, Saliba RM, Hosing C, et al
     8-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide and rituximab.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
158. HAGENBEEK A , Gadeberg O, Johnson P, Pedersen LM, et al
     First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase I/II trial.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
159. SAVAGE KJ , Harris NL, Vose JM, Ullrich F, et al
     ALK-negative anaplastic large-cell lymphoma (ALCL) is clinically and immunophenotypically different from both ALK-positive ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
160. REED JC
     Bcl-2-family proteins and hematologic malignancies: history and future prospects.
     Blood. 2008;111:3322-30.
     PubMed     Related articles    Abstract available
     
     
     
161. MENZEL C , Schirrmann T, Konthur Z, Jostock T, et al
     Human antibody RNase fusion protein targeting CD30+ lymphomas.
     Blood. 2008;111:3830-7.
     PubMed     Related articles    Abstract available
     
     
     
162. ZHOU P , Comenzo RL, Olshen AB, Bonvini E, et al
     CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy.
     Blood. 2008;111:3403-6.
     PubMed     Related articles    Abstract available
     
     
     March 2008
163. ANTICA M , Sain LC, Kapitanovic S, Matulic M, et al
     Aberrant Ikaros, Aiolos, and Helios expression in Hodgkin and non-Hodgkin lymphoma.
     Blood. 2008;111:3296-7.
     PubMed     Related articles   
     
     
     
164. KITADA S , Kress CL, Krajewska M, Jia L, et al
     Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).
     Blood. 2008;111:3211-9.
     PubMed     Related articles    Abstract available
     
     
     
165. BRENNER H , Gondos A, Pulte D
     Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients.
     Blood. 2008;111:2977-83.
     PubMed     Related articles    Abstract available
     
     
     
166. DAL COL J , Zancai P, Terrin L, Guidoboni M, et al
     Distinct functional significance of Akt and mTOR constitutive activation in mantle cell lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
167. PATTEN PE , Buggins AG, Richards J, Wotherspoon A, et al
     CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
168. BROWN PJ , Ashe SL, Leich E, Burek C, et al
     Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.
     Blood. 2008;111:2816-24.
     PubMed     Related articles    Abstract available
     
     
     February 2008
169. TASKINEN M , Karjalainen-Lindsberg ML, Leppa S
     Prognostic influence of tumor-infiltrating mast cells in follicular lymphoma patients treated with rituximab and CHOP.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
170. MITTAL S , Marshall NA, Duncan L, Culligan DJ, et al
     Local and systemic induction of CD4+CD25+ regulatory T cell population by non-Hodgkin's lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
171. SAITOH Y , Yamamoto N, Dewan MZ, Sugimoto H, et al
     Overexpressed NF-{kappa}B inducing kinase contributes to the tumorigenesis of adult T-cell leukemia and Hodgkin Reed-Sternberg cells.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
172. SCHEEREN FA , Diehl SA, Smit LA, Beaumont T, et al
     IL-21 is expressed in Hodgkin Lymphoma and activates STAT5; evidence that activated STAT5 is required for Hodgkin Lymphomagenesis.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
173. PAOLUZZI L , Gonen M, Gardner JR, Mastrella J, et al
     Targeting Bcl-2 family members with the BH3 mimetic AT-101 markedly enhances the therapeutic effects of chemotherapeutic agents in in vitro and in vivo models of B-cell lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
174. MOURAD N , Mounier N, Briere J, Raffoux E, et al
     Clinical, biological and pathological features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
175. SKIBOLA CF , Nieters A, Bracci PM, Curry JD, et al
     A functional TNFRSF5 gene variant is associated with risk of lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
176. ZHAO WL , Janin A, Chen SJ
     Response: Multiple role of PRDM1{beta} involvement in diffuse large B-cell lymphoma.
     Blood. 2008;111:2489-90.
     PubMed     Related articles   
     
     
     
177. DEANS JP , Polyak MJ
     FMC7 is an epitope of CD20.
     Blood. 2008;111:2492.
     PubMed     Related articles   
     
     
     
178. TAM W , Gomez M, Nie K
     Significance of PRDM1beta expression as a prognostic marker in diffuse large B-cell lymphomas.
     Blood. 2008;111:2488-9.
     PubMed     Related articles   
     
     
     
179. TAUZIN S , Ding H, Khatib K, Ahmad I, et al
     Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts.
     Blood. 2008;111:2310-20.
     PubMed     Related articles    Abstract available
     
     
     
180. TISSIERES P , Dunn-Siegrist I, Schappi M, Elson G, et al
     Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria.
     Blood. 2008;111:2122-31.
     PubMed     Related articles    Abstract available
     
     
     
181. LEE DY , Sugden B
     The LMP1 oncogene of EBV activates PERK and the unfolded protein response to drive its own synthesis.
     Blood. 2008;111:2280-9.
     PubMed     Related articles    Abstract available
     
     
     
182. LEVINE JE , Paczesny S, Mineishi S, Braun T, et al
     Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.
     Blood. 2008;111:2470-5.
     PubMed     Related articles    Abstract available
     
     
     
183. MARZEC M , Liu X, Kasprzycka M, Witkiewicz A, et al
     IL-2- and IL-15-induced activation of the rapamycin-sensitive mTORC1 pathway in malignant CD4+ T lymphocytes.
     Blood. 2008;111:2181-9.
     PubMed     Related articles    Abstract available
     
     
     
184. PETIT I , Karajannis MA, Vincent L, Young L, et al
     The microtubule-targeting agent CA4P regresses leukemic xenografts by disrupting interaction with vascular cells and mitochondrial-dependent cell death.
     Blood. 2008;111:1951-61.
     PubMed     Related articles    Abstract available
     
     
     
185. BASSING CH , Ranganath S, Murphy M, Savic V, et al
     Aberrant V(D)J recombination is not required for rapid development of H2ax/p53-deficient thymic lymphomas with clonal translocations.
     Blood. 2008;111:2163-9.
     PubMed     Related articles    Abstract available
     
     
     
186. FELDMAN AL , Arber DA, Pittaluga S, Martinez A, et al
     Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
187. EKSTROM SMEDBY K , Vajdic CM, Falster M, Engels EA, et al
     Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
188. BLUHM EC , Ronckers C, Hayashi RJ, Neglia JP, et al
     Cause-specific mortality and second cancer incidence after non-Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
189. THOMPSON JA , Fisher RI, Leblanc M, Forman SJ, et al
     Total body irradiation, etoposide, cyclophosphamide and autologous peripheral blood stem cell transplantation followed by randomization to therapy with Interleukin-2 versus observation for patients with non-Hodgkin's lymphoma: results of a phase III rand
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
190. HERENS C , Lambert F, Quintanilla-Martinez L, Bisig B, et al
     Cyclin D1-negative mantle cell lymphoma with cryptic t(12;14)(p13;q32) and cyclin D2 overexpression.
     Blood. 2008;111:1745-6.
     PubMed     Related articles   
     
     
     
191. DING BB , Yu JJ, Yu RY, Mendez LM, et al
     Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas.
     Blood. 2008;111:1515-23.
     PubMed     Related articles    Abstract available
     
     
     January 2008
192. LADETTO M , De Marco F, Benedetti F, Vitolo U, et al
     Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an over-all survi
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
193. ZHAO WL , Liu YY, Zhang QL, Wang L, et al
     PRDM1/BLIMP-1 is involved in chemoresistance of T-cell lymphoma and downregulated by the proteasome inhibitor.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
194. GUASPARRI I , Bubman D, Cesarman E
     EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
195. MOARBESS G , El-Hajj H, Kfoury Y, El-Sabban ME, et al
     EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase dependent apoptosis in T cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
196. YAMAMOTO R , Nishikori M, Kitawaki T, Sakai T, et al
     PD-1-PD-1-ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
197. VELLENGA E , van Putten WL, van 't Veer MB, Zijlstra JM, et al
     Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.
     Blood. 2008;111:537-43.
     PubMed     Related articles    Abstract available
     
     
     
198. HAAS J , Schopp L, Storch-Hagenlocher B, Fritzsching B, et al
     Specific recruitment of regulatory T cells into the CSF in lymphomatous and carcinomatous meningitis.
     Blood. 2008;111:761-6.
     PubMed     Related articles    Abstract available
     
     
     
199. STAGNI V , di Bari MG, Cursi S, Condo I, et al
     ATM kinase activity modulates Fas sensitivity through the regulation of FLIP in lymphoid cells.
     Blood. 2008;111:829-37.
     PubMed     Related articles    Abstract available
     
     
     
200. TUN HW , Personett D, Baskerville KA, Menke DM, et al
     Pathway analysis of primary central nervous system lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
201. BYERS RJ , Sakhinia E, Joseph P, Glennie C, et al
     Clinical quantitation of immune signature in follicular lymphoma by RT-PCR based gene expression profiling.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
202. BOWER M , Stebbing J, Tuthill M, Campbell V, et al
     Immunological recovery in survivors following chemotherapy for AIDS related non Hodgkin's lymphoma.
     Blood. 2008;.
     PubMed     Related articles    Abstract available
     
     
     
203. MONTES-MORENO S , Roncador G, Maestre L, Martinez N, et al
     Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas.
     Blood. 2008;111:351-8.
     PubMed     Related articles    Abstract available
     
     
     December 2007
204. LAM LT , Wright G, Davis RE, Lenz G, et al
     Cooperative signaling through the STAT3 and NF-{kappa}B pathways in subtypes of diffuse large B cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
205. NAVARRO A , Gaya A, Martinez A, Urbano-Ispizua A, et al
     MicroRNA expression profiling in classical Hodgkin lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
206. OFLAZOGLU E , Stone IJ, Gordon KA, Grewal IS, et al
     Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30.
     Blood. 2007;110:4370-2.
     PubMed     Related articles    Abstract available
     
     
     
207. O'HARA A , Vahrson W, Dittmer DP
     Gene alteration, pre- and mature micro RNA changes contribute to the miRNA signature of Primary Effusion Lymphoma (PEL).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
208. DETERMANN O , Hoster E, Ott G, Bernd HW, et al
     Ki-67 predicts outcome in advanced stage mantle cell lymphoma patients treated with anti-CD20 immunochemo-therapy: results from randomized trials of the European MCL Network and the German Low Grade Lymphoma Study Group.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
209. COZEN W , Gill PS, Salam MT, Nieters A, et al
     Interleukin-2, interleukin-12 and interferon-{gamma} levels and risk of young adult Hodgkin lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
210. MA Y , Visser L, Roelofsen H, de Vries M, et al
     Proteomics analysis of Hodgkin lymphoma: Identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
211. MIRMONSEF P , Tan G, Zhou G, Morino T, et al
     Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem cell transplantation.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     November 2007
212. TRAVERSE-GLEHEN A , Baseggio L, Callet-Bauchu E, Morel D, et al
     Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinico-pathological and molecular entity?
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
213. PATHAN NI , Chu P, Hariharan K, Cheney C, et al
     Mediation of apoptosis by and anti-tumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
214. QU Z , Goldenberg DM, Cardillo TM, Shi V, et al
     Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
215. KIM SW , Oleksyn DW, Rossi RM, Jordan CT, et al
     Protein kinase C-associated kinase PKK is required for NF-{kappa}B signaling and survival in diffuse large B-cell lymphoma cells.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
216. ORTEGA-PAINO E , Fransson J, Ek S, Borrebaeck CA, et al
     Functionally-associated targets in mantle cell lymphoma as defined by DNA microarrays and RNA interference.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
217. CHEN L , Monti S, Juszczynski P, Daley J, et al
     SYK-dependent tonic B-cell receptor signaling is a rational treatment target in diffuse large B-cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
218. MANCAO C , Hammerschmidt W
     Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival.
     Blood. 2007;110:3715-21.
     PubMed     Related articles    Abstract available
     
     
     
219. FRANKI SN , Steward KK, Betting DJ, Kafi K, et al
     Dendritic cells loaded with apoptotic antibody-coated tumor cells provide protective immunity against B cell lymphoma in vivo.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
220. RODRIGUEZ-ANTONA C , Leskela S, Zajac M, Cuadros M, et al
     Expression of CYP3A4 as a predictor of response to chemotherapy in peripheral T-cell lymphomas.
     Blood. 2007;110:3345-51.
     PubMed     Related articles    Abstract available
     
     
     October 2007
221. DOOLITTLE ND , Abrey LE, Shenkier TN, Siegal T, et al
     Brain parenchyma involvement as isolated central nervous system (CNS) relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
222. HOSTER E , Dreyling M, Klapper W, Gisselbrecht C, et al
     A new prognostic index (MIPI) for patients with advanced stage mantle cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
223. FOX E , Razzouk BI, Widemann BC, Xiao S, et al
     Phase I trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia including acute promyelocytic leukemia or lymphoma A collaborative study of The Pediatric Oncology Branch, National Cancer
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
224. LE DELEY MC , Reiter A, Williams D, Delsol G, et al
     Prognostic factors in childhood anaplastic large cell lymphoma : results of a large European Intergroup Study.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
225. SCHULZ H , Rehwald U, Morschhauser F, Elter T, et al
     Rituximab in relapsed lymphocyte-predominant Hodgkin Lymphoma: Long-term results of a phase-II trial of the German Hodgkin Lymphoma Study Group (GHSG).
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
226. REIMANN M , Loddenkemper C, Rudolph C, Schildhauer I, et al
     The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
     Blood. 2007;110:2996-3004.
     PubMed     Related articles    Abstract available
     
     
     
227. WILLEMZE R , Jansen PM, Cerroni L, Berti E, et al
     Subcutaneous panniculitis-like T-cell lymphoma: definition, classification and prognostic factors. An EORTC Cutaneous Lymphoma Group study of 83 cases.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
228. EK S , Dictor M, Jerkeman M, Jirstrom K, et al
     Nuclear expression of the non-B cell lineage Sox11 transcription factor identifies mantle cell lymphoma.
     Blood. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
229. SHACHAF CM , Perez OD, Youssef S, Fan AC, et al
     Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
     Blood. 2007;110:2674-84.
     PubMed     Related articles    Abstract available
     
     
     
230. SPAULDING C , Reschly EJ, Zagort DE, Yashiro-Ohtani Y, et al
     Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas.
     Blood. 2007;110:2650-8.
     PubMed     Related articles    Abstract available
     
     
     
231. PEREZ-PERSONA E , Vidriales MB, Mateo G, Garcia-Sanz R, et al
     New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.
     Blood. 2007;110:2586-92.
     PubMed     Related articles    Abstract available
     
     
     
232. DAVENPORT EL , Moore HE, Dunlop AS, Sharp SY, et al
     Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells.
     Blood. 2007;110:2641-9.
     PubMed     Related articles    Abstract available
     
     
     
233. GOEL A , Carlson SK, Classic KL, Greiner S, et al
     Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene.
     Blood. 2007;110:2342-50.
     PubMed     Related articles    Abstract available
     
     
     
234. SAVOLDO B , Rooney CM, Di Stasi A, Abken H, et al
     Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease.
     Blood. 2007;110:2620-30.
     PubMed     Related articles    Abstract available
     
     
     September 2007
235. FREDRIKSEN AB , Bogen B
     Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences.
     Blood. 2007;110:1797-805.
     PubMed     Related articles    Abstract available
     
     
     
236. PEI XY , Dai Y, Tenorio S, Lu J, et al
     MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.
     Blood. 2007;110:2092-101.
     PubMed     Related articles    Abstract available
     
     
     
237. YANG Y , MacLeod V, Dai Y, Khotskaya-Sample Y, et al
     The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy.
     Blood. 2007;110:2041-8.
     PubMed     Related articles    Abstract available
     
     
     
238. DAHLE J , Borrebaek J, Jonasdottir TJ, Hjelmerud AK, et al
     Targeted cancer therapy with a novel low-dose rate alpha-emitting radioimmunoconjugate.
     Blood. 2007;110:2049-56.
     PubMed     Related articles    Abstract available
     
     
     
239. QIAN J , Xie J, Hong S, Yang J, et al
     Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.
     Blood. 2007;110:1587-94.
     PubMed     Related articles    Abstract available
     
     
     
240. TAI YT , Fulciniti M, Hideshima T, Song W, et al
     Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis.
     Blood. 2007;110:1656-63.
     PubMed     Related articles    Abstract available
     
     
     
241. LWIN T , Hazlehurst LA, Dessureault S, Lai R, et al
     Cell adhesion induces p27Kip1-associated cell-cycle arrest through down-regulation of the SCFSkp2 ubiquitin ligase pathway in mantle-cell and other non-Hodgkin B-cell lymphomas.
     Blood. 2007;110:1631-8.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: